PUBLISHER: TechSci Research | PRODUCT CODE: 2048271
PUBLISHER: TechSci Research | PRODUCT CODE: 2048271
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Veterinary Point of Care Diagnostics Market is projected to see significant growth, expanding from USD 2.12 Billion in 2025 to USD 3.92 Billion by 2031, achieving a Compound Annual Growth Rate (CAGR) of 10.79%. These diagnostics consist of portable instruments and consumables that enable veterinarians to perform immediate analyses at the animal care site, thereby reducing the need for external reference laboratories. This market is primarily driven by the increasing prevalence of companion animal ownership and owners' growing willingness to invest in premium healthcare services for their pets. This escalating demand necessitates rapid clinical decision-making capabilities, allowing practitioners to diagnose and initiate treatment within a single consultation. As an indicator of this substantial market base, FEDIAF reported that 139 million European households owned at least one pet in 2025.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.12 Billion |
| Market Size 2031 | USD 3.92 Billion |
| CAGR 2026-2031 | 10.79% |
| Fastest Growing Segment | Home Care Settings |
| Largest Market | North America |
Despite these strong growth projections, the market faces a significant hurdle due to the shortage of skilled veterinary professionals. This scarcity limits clinics' capacity to efficiently adopt and manage new diagnostic workflows, leading to underutilization of available technologies and impeding the overall expansion of point-of-care testing within veterinary practices.
Market Driver
Technological advancements in portable and automated diagnostic systems are fundamentally transforming the Global Veterinary Point of Care Diagnostics Market by providing reference-lab quality results directly within the clinic. The integration of artificial intelligence and connectivity into benchtop analyzers empowers veterinarians with immediate, accurate interpretations of complex samples, enabling real-time treatment decisions. This shift is rapidly accelerating the installation of sophisticated hardware worldwide; for instance, IDEXX Laboratories, Inc. reported placing over 1,700 units of its innovative inVue Dx instruments globally in just one quarter during 2025, reflecting intense demand for these advanced capabilities. Furthermore, increasing animal healthcare expenditure and the growing penetration of pet insurance are catalyzing market expansion by removing financial obstacles to comprehensive testing. As insurance coverage becomes more widespread, pet owners are increasingly able to authorize extensive diagnostic panels during initial visits without undue cost concerns, leading to higher utilization rates of point-of-care devices. This financial support is substantial, with the North American Pet Health Insurance Association (NAPHIA) reporting total written premiums exceeding $5.2 billion USD by the end of 2024, complemented by total pet industry expenditures in the United States reaching $152 billion in 2025, according to the American Pet Products Association.
Market Challenge
The shortage of skilled veterinary professionals represents a critical bottleneck hindering the growth of the Global Veterinary Point of Care Diagnostics Market. While point-of-care devices are designed to accelerate clinical decision-making, they require a baseline of available personnel to operate, interpret results from, and maintain the equipment. Clinics facing staffing deficits often find their existing veterinary teams overwhelmed with patient volume, leaving insufficient capacity to integrate new diagnostic workflows or undergo necessary training for advanced portable systems. Consequently, practices frequently revert to sending samples to external reference laboratories to conserve immediate staff resources, effectively negating the speed advantage that drives the adoption of point-of-care solutions. This labor constraint severely impacts market expansion by creating an environment where practice owners are hesitant to invest in premium technology. The British Veterinary Association reported in 2024 that over one-third of veterinarians were unsure of their future in the sector or actively planning to leave, highlighting a high potential turnover that exacerbates the workforce crisis and directly limits the capacity of veterinary clinics to utilize and justify the cost of immediate diagnostic instruments.
Market Trends
Advancements in microfluidic and lab-on-a-chip technologies are fundamentally altering the operational efficiency and physical footprint of veterinary clinics by miniaturizing complex fluid handling into single-use cartridges. This technological shift enables practitioners to analyze significantly smaller sample volumes, which is crucial for pediatric or dehydrated animal patients, while also eliminating the extensive maintenance and liquid reagent storage typically associated with traditional benchtop systems. By precisely manipulating fluids at the sub-millimeter scale, these compact devices facilitate immediate analysis and cellular alignment without requiring large-scale laboratory infrastructure. An example is Zoetis Inc.'s September 2024 unveiling of the Vetscan OptiCell, a diagnostic instrument utilizing proprietary microfluidic technology to align blood cells in a single layer for analysis, marking a significant departure from standard flow cytometry methods.
Concurrently, the market is undergoing a decisive shift towards cloud-based practice management integration, which transforms diagnostic instruments from standalone tools into connected nodes within a comprehensive digital ecosystem. This trend focuses on improving workflow efficiency by directly synchronizing point-of-care hardware with patient information systems, ensuring test results are automatically populated into medical records to prevent manual entry errors and guarantee accurate billing capture. Veterinary practices are prioritizing these integrated platforms to facilitate longitudinal patient tracking and streamline the administrative burden associated with high-volume testing. For instance, IDEXX Laboratories, Inc. reported an 11% increase in revenue from its Veterinary Software, Services and Diagnostic Imaging segment in Q3 2024, a performance primarily driven by the continued double-digit organic growth of its cloud-based software solutions.
Report Scope
In this report, the Global Veterinary Point of Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Point of Care Diagnostics Market.
Global Veterinary Point of Care Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: